Study identifier:NIS-OIT-DUM-2006/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Retrospective observational trial on reasons for withdraw of Adjuvant Tamoxifen in Breast Cancer patients
Breast Cancer
-
No
-
Female
190
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
1 Post menopausal women treated with adjuvant TAM for breast cancer | - |